Search

Since 2009, the European Centre for Disease Prevention and Control has coordinated the enhanced surveillance of sexually transmitted infections in Europe.

In 2010, 21 EU/EEA Member States participated in the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), testing a total of 1766 isolates.

In 2011, a pilot study was undertaken to assess the public health benefit of molecular surveillance for gonorrhoea in 21 EU/EEA countries. A total of 1 066 isolates collected under the 2010 European gonococcal antimicrobial surveillance programme were typed and 406 sequence types identified, with considerable diversity among countries.

This report presents the results from the 2011 gonococcal antimicrobial susceptibility surveillance programme (Euro-GASP) and a summary of the second distribution from the 2011 external quality assurance (EQA) scheme.

This report gives an overview of the current status of STI and HIV among men who have sex with men (MSM) in EU/EEA countries. It reviews HIV and STI prevention interventions targeted at MSM, and the evaluations of those interventions.

This report presents the main findings of an ECDC project to assess the burden of infectious diseases among migrants in the EU/EEA based on available data for specific diseases: human immunodeficiency virus (HIV), tuberculosis (TB), hepatitis B, hepatitis C, gonorrhoea, syphilis, measles and rubella, malaria and Chagas disease.

​This report summarises the surveillance results for Neisseria gonorrhoeae antimicrobial susceptibility in the EU/EEA. In 2012, 20 EU/EEA Member States participated in Euro-GASP.

During 2013, the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) followed the biannual decentralised and centralised testing model used in previous years, requesting participating laboratories to collect gonococcal isolates during two periods (April/May and October/November).

The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC) since 2009.